<UMA 00-19>Chlamydial Glycolipid Vaccines and Methods for Synthesis

The Portal is a joint project of MATTO and the MTTC. The development and implementation of the portal has been paid for by the MTTC, Beth Israel Deaconess Medical Center, Boston Biomedical Research Institute, Boston University, Brandeis University, Caritas St. Elizabeth's Medical Center, Boston Children's Hospital, Dana Farber Cancer Institute, Harvard University, Joslin Diabetes Center, Massachusetts Eye and Ear Infirmary, Massachusetts General Hospital, McLean Hospital, Northeastern University, The Schepens Eye Research Institute, and Tufts University.

Intellectual Property

ID:		UMA 00-19 and UMA 01-04
IP Type:		Licensable Technology
Title:		Chlamydial Glycolipid Vaccines and Methods for Synthesis
Inventor:		E.S. Stuart and L.H. Semprevivo
Summary:		A conjugate vaccine made from the Chlamydial Glycolipid Exo-antigen (GLXA) which elicits a protective immune response against the sexually transmitted disease of the genus Chlamydia.
Tech Type:		Therapeutics - Drugs and Vaccines \| Therapeutics - Drugs and Therapeutics - Methods \| Therapeutics - Drugs and Vaccines \| Therapeutics - Drugs and Therapeutics - Methods
URL:		http://amherst.cvip-umass.net/index.cfm?fuseaction=tech.index
Contact:		Office of Commercial Ventures and Intellectual Property Phone: 413-545-3606 FAX: 413-545-3632 E-Mail: cvip@research.umass.edu
Organization:		University of Massachusetts at Amherst

Display all intellectual properties for E.S. Stuart and L.H. Semprevivo
Display all intellectual properties for University of Massachusetts at Amherst